Aetiopathogenetic Architecture for Pharmaceutical Development (Using Gout as a Case Study)

INTRODUCTION. A holistic understanding of the physiological and biochemical pathways involved in pathogenesis is needed both for doctors diagnosing and treating patients and for drug developers. The accumulated knowledge in medicine and related fields, combined with the rapid development of digital...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Avdeeva, N. R. Varina, T. K. Ryazanova, V. A. Kurkin, N. V. Isakova, L. T. Volova, D. A. Poltoretskii
Format:	Article
Language:	Russian
Published:	Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2023-08-01
Series:	Регуляторные исследования и экспертиза лекарственных средств
Subjects:	pathogenesis sanogenesis aetiopathogenetic clusters diagnosis of conditions experimental models of aetiopathogenesis pharmaceutical development gout aetiopathogenesis
Online Access:	https://www.vedomostincesmp.ru/jour/article/view/724
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Aetiopathogenetic Architecture for Pharmaceutical Development (Using Gout as a Case Study)

Similar Items